CATINAZZO THOMAS (Vice President, Finance) sold 13.4% of their position (58.94K shares) of RELAY THERAPEUTICS, INC. on the open market
Open‑market sale worth $268.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 1/30/2025ACC: 0000950170-25-011327
Officer· Vice President, Finance
Since Jul 2020
+80.20K
Net shares
Net buyer
$268.3K
Total sold
4
Open market trades
0B · 4S
5
Total transactions
139.14K acquired · 58.94K disposed
Non-Derivative Transactions5
Common Stock
Direct
Shares
−33.75K
Price / share
$4.63
Trade value
$156.28K
% of position
11.3%
1/28/2025
299.23K→265.47K
Common Stock
Direct
Shares
−2.28K
Price / share
$4.63
Trade value
$10.57K
% of position
0.9%
1/28/2025
265.47K→263.19K
Common Stock
Direct
Shares
+139.14K
Price / share
—
Trade value
—
% of position
52.9%
1/28/2025
263.19K→402.33K
Common Stock
Direct
Shares
−2.11K
Price / share
$4.55
Trade value
$9.60K
% of position
0.5%
1/29/2025
402.33K→400.22K
Common Stock
Direct
Shares
−20.79K
Price / share
$4.42
Trade value
$91.90K
% of position
5.2%
1/30/2025
400.22K→379.43K
Total
Net shares
+80.20K
Net value
-$268.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/28/2025 | S · Sale | −33.75K | $4.63 | $156.28K | 11.3% | 299.23K | 265.47K |
| Common Stock Direct | 1/28/2025 | S · Sale | −2.28K | $4.63 | $10.57K | 0.9% | 265.47K | 263.19K |
| Common Stock Direct | 1/28/2025 | A · Award | +139.14K | — | — | 52.9% | 263.19K | 402.33K |
| Common Stock Direct | 1/29/2025 | S · Sale | −2.11K | $4.55 | $9.60K | 0.5% | 402.33K | 400.22K |
| Common Stock Direct | 1/30/2025 | S · Sale | −20.79K | $4.42 | $91.90K | 5.2% | 400.22K | 379.43K |
| Total | +80.20K | -$268.34K | ||||||
Derivative Transactions0
No derivative transactions reported